Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 400 of 3173 entries
View as:

Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00174239 Org: User:
Start: 07/31/04 End: 09/30/05 Due: 09/30/06

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

Phase: N/A Priority: Normal
NCT ID: NCT05226871 Org: User:
Start: 07/07/22 End: 12/31/26 Due: 12/31/27

A Study to Learn How Different Amounts of the Study Medicine Called PF-07314470 Are Tolerated and Act in the Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06821750 Org: User:
Start: 02/11/25 End: 06/09/26 Due: 06/09/27

Studying An Investigational Drug Crizotinib (PF-02341066) In Non Non-Small Cell Lung Cancer Tumors That Are Positive For Anaplastic Lymphoma Kinase (ALK)

Phase: N/A Priority: Normal
NCT ID: NCT01121588 Org: User:
Start: 03/22/11 End: 09/07/23 Due: 09/07/24

A Study To Test The Impact Of PF- 00299804 On How The Body Handles Dextromethorphan In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00728468 Org: User:
Start: 09/30/08 End: 07/31/14 Due: 07/31/15

Impact Of RA Therapy Compliance On Patient-Reported Outcomes

Phase: N/A Priority: Normal
NCT ID: NCT01438892 Org: User:
Start: 02/29/12 End: 01/31/13 Due: 01/31/14

Treatment Use Study for Advanced Melanoma.

Phase: N/A Priority: Normal
NCT ID: NCT00584493 Org: User:
Start: 05/31/08 End: - Due: -

A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy

Phase: N/A Priority: Normal
NCT ID: NCT01006122 Org: User:
Start: 11/30/09 End: 11/30/10 Due: 11/30/11

A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants.

Phase: N/A Priority: Normal
NCT ID: NCT00832052 Org: User:
Start: 01/31/09 End: 05/31/09 Due: 05/31/10

A Study to Assess the Pharmacokinetics of Ceftaroline in End Stage Renal Disease Patients and Matched Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01664065 Org: User:
Start: 02/28/13 End: 11/30/13 Due: 11/30/14

An Open, Non-Comparative Study of Intravenous and Oral Fluconazole in the Treatment of Acute Cryptococcal Meningitis

Phase: N/A Priority: Normal
NCT ID: NCT00002077 Org: User:
Start: - End: - Due: -

Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02974374 Org: User:
Start: 10/31/16 End: 01/31/17 Due: 01/31/18

Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip

Phase: N/A Priority: Normal
NCT ID: NCT00809354 Org: User:
Start: 02/12/09 End: 01/12/11 Due: 01/12/12

A Clinical Study in Patients With Overactive Bladder With Leakage of Urine, to Find Out if the Medicine, Fesoterodine, Works in Those Patients Who Did Not Have Enough Response to the Medicine, Tolterodine.

Phase: N/A Priority: Normal
NCT ID: NCT01302054 Org: User:
Start: 05/31/11 End: 05/31/12 Due: 05/31/13

Effect of Diltiazem Administration on CP-945,598 Pharmacokinetics

Phase: N/A Priority: Normal
NCT ID: NCT00645463 Org: User:
Start: 03/31/07 End: 06/30/07 Due: 06/30/08

Anti-Angiogenesis Agent AG-013736 In Patients With Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00094107 Org: User:
Start: 12/31/04 End: 04/30/08 Due: 04/30/09

To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 Days

Phase: N/A Priority: Normal
NCT ID: NCT00300677 Org: User:
Start: 03/31/07 End: 08/31/08 Due: 08/31/09

A Phase 1 Study To Evaluate Tolerability, Safety, And Pharmacokinetics Of Topical PF-06263276 In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01981681 Org: User:
Start: 11/30/13 End: 06/30/14 Due: 06/30/15

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Champix® Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00483002 Org: User:
Start: 06/30/07 End: 05/31/11 Due: 05/31/12

Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose

Phase: N/A Priority: Normal
NCT ID: NCT01543087 Org: User:
Start: 09/07/12 End: 01/05/18 Due: 01/05/19

Vyndaqel Capsules Special Investigation (ATTR-CM)

Phase: N/A Priority: Normal
NCT ID: NCT04108091 Org: User:
Start: 10/03/19 End: 03/27/25 Due: 03/27/26

Clinical Outcomes for Patients With Renal Cell Carcinoma Who Received First-Line Sunitinib

Phase: N/A Priority: Normal
NCT ID: NCT04076787 Org: User:
Start: 09/01/18 End: 09/02/18 Due: 09/02/19

Study Of Axitinib In Combination With Cisplatin And Capecitabine In Patients With Advanced Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00842244 Org: User:
Start: 04/30/09 End: 10/31/12 Due: 10/31/13

12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation

Phase: N/A Priority: Normal
NCT ID: NCT00139750 Org: User:
Start: 12/31/04 End: 02/28/06 Due: 02/28/07

Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00058838 Org: User:
Start: 04/30/03 End: 09/30/04 Due: 09/30/05